Singleton versus duplicate assays in maternal serum screening

Comment

P A Benn. Prenat Diagn. 2001 Oct.

. 2001 Oct;21(10):894-6.

doi: 10.1002/pd.159.

No abstract available

Comment on

Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets.
Bray I, Wright DE, Davies C, Hook EB. Bray I, et al. Prenat Diagn. 1998 Jan;18(1):9-20. Prenat Diagn. 1998. PMID: 9483635
Economic evaluation of prenatal screening for Down syndrome in the U.S.A.
Beazoglou T, Heffley D, Kyriopoulos J, Vintzileos A, Benn P. Beazoglou T, et al. Prenat Diagn. 1998 Dec;18(12):1241-52. doi: 10.1002/(sici)1097-0223(199812)18:12<1241::aid-pd440>3.0.co;2-m. Prenat Diagn. 1998. PMID: 9885015
Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects.
Hackshaw AK, Wald NJ, George LM. Hackshaw AK, et al. Prenat Diagn. 2001 Jan;21(1):72. doi: 10.1002/1097-0223(200101)21:1<72::aid-pd989>3.0.co;2-t. Prenat Diagn. 2001. PMID: 11180247 No abstract available.